EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form Trypanosoma brucei brucei

Pearl Ihuoma Akazue, Neils Ben Quashie, Sue Vaughan, Harry P de Koning, Theresa Manful Gwira

Experimental Biology and Medicine · 12.06.2026 · 251

DOI: 10.3389/ebm.2026.10979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 12.06.2026. Verfasst von Pearl Ihuoma Akazue und 4 weiteren Autor:innen. Beteiligte Einrichtung: West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, Trypanocidal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Open-access drug discovery platforms have accelerated hit identification and lead prioritization across multiple diseases and enable systematic repurposing of bioactive compounds beyond their original indications. However, there remains a need for new chemotypes for African trypanosomiasis with improved efficacy and resilience to emerging drug resistance. In this study, we evaluated the antitrypanosomal potential and cellular effects of two Pathogen Box compounds, MMV667494 and MMV028694. The compounds were selected through a resazurin-based in vitro phenotypic viability screen that measures metabolic activity as a proxy for parasite viability against bloodstream-form Trypanosoma brucei brucei . To explore cellular phenotypes consistent with potential mechanisms of action, we applied cytological profiling using flow cytometry- and microscopy-based assays, including Annexin V/propidium iodide staining, cell-cycle DNA-content analysis, mitochondrial membrane potential (TMRE), and mitochondrial reactive oxygen species (MitoSOX) measurements. Both MMV667494 and MMV028694 (IC 50 = 0.44 ± 0.05 µM and 0.33 ± 0.03 µM, respectively) displayed sub-micromolar antitrypanosomal potency and preferential toxicity toward trypanosomes over mammalian cells (selectivity indices >10). Growth profiling demonstrated dose-dependent inhibition of parasite proliferation, with evidence of trypanocidal activity at higher concentrations and longer exposure times. Treatment resulted in increased populations of phosphatidylserine-exposed and membrane-compromised cells, which is consistent with apoptosis-like phenotypes in trypanosomes. Although both compounds induced mitochondrial membrane depolarization in treated T. b. brucei cells, this effect was observed predominantly in a subpopulation of cells and is therefore unlikely to represent the primary cause of cell death. Increased mitochondrial production of reactive oxygen species and altered cell-cycle progression were also observed, which might indicate disruption of key cellular processes. These findings shows that MMV667494 and MMV028694 are selective antitrypanosomal compounds and their activities are associated with induce apoptosis-like features, cell-cycle disruption, and mitochondrial stress signatures in bloodstream-form T. b. brucei . These findings provide phenotypic insights into the activity of the compounds, warranting further target deconvolution and optimization, although validation in human-infective subspecies and in vivo systems will be required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma brucei bruceiTrypanocidal AgentsMembrane Potential, MitochondrialReactive Oxygen SpeciesAnimalsFlow CytometryTrypanosomiasis, AfricanPhenotype

Stichwörter der Autor:innen

African trypanosomiasisPathogen Boxantitrypanosomal activitymitochondrial reactive oxygen speciesmitochondrial stress

Substanzen

Trypanocidal AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana.
  • Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.
  • Department of Biochemistry, Faculty of Life Sciences, University of Benin, Benin City, Nigeria.
  • Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, Accra, Ghana.
  • Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, United Kingdom.
  • School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.

Förderung

  • Academy of Medical Sciences

Zitieren

APA

Akazue, P. I., Quashie, N. B., Vaughan, S., de Koning, H. P., & Gwira, T. M. (2026). Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form Trypanosoma brucei brucei. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.10979

Vancouver

Akazue PI, Quashie NB, Vaughan S, de Koning HP, Gwira TM. Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form Trypanosoma brucei brucei. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.10979

BibTeX
@article{Akazue2026,
  author = {Akazue, Pearl Ihuoma and Quashie, Neils Ben and Vaughan, Sue and de Koning, Harry P and Gwira, Theresa Manful},
  title = {Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form Trypanosoma brucei brucei},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.10979}
}
Kostenlos starten →